用于瘤特异化疗/铁结合治疗的pH/GSH双响应多重药物
1State Key Laboratory of Natural Product Chemistry, College of Chemistry and Chemical Engineering, Lanzhou University, Lanzhou 730000, China.
Bioconjugate chemistry
|August 28, 2025
概括
这项研究引入了P(DOXss-Fc) -PEG纳米颗粒,可在癌细胞中选择性地诱导铁. 这些纳米颗粒显示出增强的抗瘤活性和协同效应,为传统化疗提供了有希望的替代品.
科学领域:
- 生物医学工程
- 纳米技术
- 癌症治疗
背景情况:
- 传统化疗因瘤异质性,耐药性和毒性而面临限制.
- 铁死是一种依赖于铁的细胞死亡, 是补充化疗的新疗法.
研究的目的:
- 为瘤选择性和协同性癌症治疗设计和合成pH/GSH双响应的两性共聚药物纳米粒子.
- 研究这些纳米颗粒在诱导铁和增强化疗中的有效性.
主要方法:
- 与二硫化物结合的多克索鲁比辛二聚体 (DOXss) 和铁素二碳水化合物 (FcDH) 的多重凝结形成P(DOXss-Fc) -PEG纳米粒子.
- 在生理和瘤状况下,纳米粒子大小,稳定性和药物释放的特征.
- 在HepG2和L02细胞中细胞吸收,药物积累,细胞毒性和协同作用的体外评估.
主要成果:
- P(DOXss-Fc) -PEG纳米颗粒具有均的大小 (~95 nm),良好稳定性和最小的药物泄漏.
- 在类似瘤的条件下观察到有效的细胞内药物释放,GSH耗尽和增强的铁死.
- 与自由多克索鲁相比,纳米颗粒显示出增强的抗瘤活性 (较低的IC50) 和协同作用 (CI=0. 95),对正常细胞的毒性降低.
结论:
- 开发的P(DOXss- Fc) - PEG纳米颗粒有效地提供多克索鲁比辛并以瘤特异的方式诱导铁.
- 这些纳米粒子为协同治疗癌症提供了一个有前途的平台, 克服了传统化疗的局限性.
相关概念视频
Combination Therapies and Personalized Medicine
5.1K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
5.1K
Targeted Cancer Therapies
7.8K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.8K


